Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables (2019 - 2024)

Historic Receivables for IM Cannabis (IMCC) over the last 6 years, with Q4 2024 value amounting to $10.1 million.

  • IM Cannabis' Receivables rose 5969.32% to $10.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.1 million, marking a year-over-year increase of 5969.32%. This contributed to the annual value of $10.3 million for FY2024, which is 6148.13% up from last year.
  • IM Cannabis' Receivables amounted to $10.1 million in Q4 2024, which was up 5969.32% from $6.3 million recorded in Q4 2023.
  • In the past 5 years, IM Cannabis' Receivables ranged from a high of $14.7 million in Q4 2021 and a low of $4.3 million during Q4 2020
  • Its 5-year average for Receivables is $8.4 million, with a median of $6.5 million in 2022.
  • Per our database at Business Quant, IM Cannabis' Receivables surged by 24128.65% in 2021 and then plummeted by 5543.64% in 2022.
  • IM Cannabis' Receivables (Quarter) stood at $4.3 million in 2020, then skyrocketed by 241.29% to $14.7 million in 2021, then plummeted by 55.44% to $6.5 million in 2022, then decreased by 3.52% to $6.3 million in 2023, then soared by 59.69% to $10.1 million in 2024.
  • Its Receivables was $10.1 million in Q4 2024, compared to $6.3 million in Q4 2023 and $6.5 million in Q4 2022.